China Neurology Devices Market Size, Share Outlook, Growth Analysis Report and Forecast Trends 2026-2030

China's neurology devices market covers a comprehensive range of products for managing neurological disorders, spanning cerebrovascular interventions to implantable neuromodulation systems. Valued at approximately $0.27 billion in 2025 with a projected 7.18% compound annual growth rate, the sector is supported by demographic shifts and rising disease prevalence. Major product categories include neurovascular embolization devices, intracranial stents, neuroendoscopes, deep brain stimulation systems, and hydrocephalus management products.

• •Market valued at approximately $0.27 billion in 2025 with a projected 7.18% compound annual growth rate
• •Product categories span neurovascular, neuromodulation, neurosurgical, hydrocephalus, and interventional neuroradiology devices
• •Hospitals and specialty neurology centers account for the majority of device procurement in the region

China's rapidly aging population is a primary catalyst, as neurological disorders such as stroke and neurodegenerative diseases increase significantly with age. The country also faces a growing burden of lifestyle-related neurological conditions, including hypertension-driven cerebrovascular disease, which elevates demand for interventional and surgical devices. Expanding health insurance coverage and increased government investment in tertiary care infrastructure are enabling broader access to advanced neurological treatments across diverse patient populations.

• •Aging demographics and rising prevalence of stroke, Parkinson's disease, and other neurological disorders
• •Expanding medical insurance coverage and government investment in hospital infrastructure and equipment
• •Growing adoption of minimally invasive interventional procedures over traditional open surgical approaches

The market is segmented by device type into neurovascular devices, neuromodulation systems, neurosurgical products, hydrocephalus shunts, and interventional neuroradiology equipment, with neurovascular and interventional segments showing particularly strong momentum. Geographically, demand is concentrated in economically developed eastern coastal provinces including Beijing, Shanghai, and Guangdong, where advanced hospital networks and higher patient access prevail. Central and western regions are emerging as incremental growth markets as healthcare infrastructure development and insurance expansion accelerate under national policy initiatives.

• •Neurovascular and interventional neuroradiology devices represent the fastest-growing product segments
• •Major demand centers are located in Beijing, Shanghai, Guangdong, Jiangsu, and other eastern coastal provinces
• •Central and western regions are gradually expanding market penetration through infrastructure development programs

What are the recent trends and outlook?

Technological trends point toward greater adoption of minimally invasive neurointerventional techniques, advanced imaging-guided navigation systems, and next-generation neuromodulation platforms. Domestic manufacturing is expected to rise as China's government continues to incentivize local production and reduce reliance on imported devices through regulatory streamlining and procurement reforms favoring domestic suppliers. Over the forecast period, the market is anticipated to maintain steady expansion driven by sustained healthcare investment, an aging population, and ongoing clinical adoption of innovative neurological therapies.

• •Increasing shift toward minimally invasive procedures and image-guided neurosurgical navigation technologies
• •Government policies encouraging domestic production and regulatory support for locally developed medical devices
• •Long-term growth expected to be sustained by aging demographics and continuous clinical innovation adoption